Source: Healio Coverage
June 09, 2021
1 min read

Top in endocrinology: Ovarian endometriosis, testosterone therapy

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Recent data revealed an association between circadian rhythm misalignment and an increased risk for ovarian endometriosis. A review of the findings was the top story in endocrinology last week.

Another top story was about the efficacy of 2-year therapy with testosterone undecanoate in men with obesity, functional hypogonadism and type 2 diabetes. Researchers said the therapy stabilized testosterone levels and improved nonalcoholic fatty liver disease grades among participants.

Testosterone drawing Adobe
Source: Adobe Stock

Read these and more top stories in endocrinology below:

Circadian rhythm misalignment may increase risk for ovarian endometriosis in women

Women with circadian rhythm misalignment may be at a greater risk for developing ovarian endometriosis, according to data presented at the European Congress of Endocrinology. Read more.

Long-term testosterone therapy may improve NAFLD symptoms in men

Two-year therapy with testosterone undecanoate normalized serum testosterone levels and reduced nonalcoholic fatty liver disease grade among men with obesity, functional hypogonadism and type 2 diabetes, data show. Read more.

Women with type 1 diabetes reach CGM targets later in pregnancy

Pregnant women with type 1 diabetes using a continuous glucose monitor improved their time in range from their first trimester to 34 weeks of pregnancy, according to study data. Read more.

Bilateral oophorectomy increases risk for severe carpal tunnel syndrome

Premenopausal women who underwent bilateral oophorectomy had a higher risk for severe carpal tunnel syndrome compared with women who did not have the procedure, according to a study published in Menopause. Read more.

Dasiglucagon studies show safety for children, adults experiencing severe hypoglycemia

A next-generation glucagon analog provided rapid and effective treatment of severe hypoglycemia for children and adults with type 1 diabetes, without the need to reconstitute lyophilized powder used in traditional glucagon rescue kits. Read more.